Shareholder Alert: The Ademi Firm investigates whether Exact Sciences Corporation is obtaining a Fair Price for its Public Shareholders

Group 1 - Exact Sciences is under investigation by the Ademi Firm for potential breaches of fiduciary duty related to its transaction with Abbott [1][3] - In the transaction, Exact Sciences shareholders will receive $105 per share, totaling an equity value of approximately $21 billion and an estimated enterprise value of $23 billion [2] - The transaction agreement includes a significant penalty for Exact Sciences if it accepts a competing bid, raising concerns about the board's fulfillment of fiduciary duties to shareholders [3]